Contribution of neural cell death to depressive phenotypes of streptozotocin-induced diabetic mice

DMM Disease Models and Mechanisms

Volumn 7, Issue 6, 2014, Pages 723-730

  Chen, Cheng ^a   Wang, Yun ^a   Zhang, Juan ^a   Ma, Lian ^a   Gu, Jiang ^a   Ho, Guyu ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Apoptosis; Comorbidity; Depression; Diabetes; Mitochondria; Neurodegeneration

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; DYNAMIN RELATED PROTEIN 1; FISSION PROTEIN 1; GLUCOSE; MESSENGER RNA; MITOFUSIN 1; MITOFUSIN 2; OPTICS ATROPHY 1 PROTEIN; PROTEIN; PROTEIN BCL 2; PROTEIN DRP1; UNCLASSIFIED DRUG; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; APOPTOSIS; ARTICLE; BEHAVIOR DISORDER; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FRONTAL CORTEX; FUSION GENE; GENE EXPRESSION; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; HYPERGLYCEMIA; IMMUNOHISTOLOGY; MALE; MITOCHONDRIAL DYNAMICS; MOUSE; MOUSE MODEL; NERVE CELL NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; ANIMAL BEHAVIOR; CELL DEATH; COMPLICATION; CYTOLOGY; EXPERIMENTAL DIABETES MELLITUS; FRONTAL LOBE; MAJOR DEPRESSION; METABOLISM; NERVE CELL; PATHOLOGY;

ANIMALS; APOPTOSIS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DEATH; DEPRESSIVE DISORDER, MAJOR; DIABETES MELLITUS, EXPERIMENTAL; FRONTAL LOBE; HIPPOCAMPUS; IN SITU NICK-END LABELING; MICE; NEURONS; STREPTOZOCIN;

EID: 84902291521     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.016162     Document Type: Article

References (56)

1. Ali, S., Stone, M. A., Peters, J. L., Davies, M. J. and Khunti, K. (2006). The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet. Med. 23, 1165-1173. (Pubitemid 44600576)
2. Ansley, D. M. and Wang, B. (2013). Oxidative stress and myocardial injury in the diabetic heart. J. Pathol. 229, 232-241.
3. Barnard, K. D., Skinner, T. C. and Peveler, R. (2006). The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review. Diabet. Med. 23, 445-448.
4. Bassil, F., Fernagut, P. O., Bezard, E. and Meissner, W. G. (2014). Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification? Prog. Neurobiol.
5. Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C. and Scheltens, P. (2006). Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 5, 64-74. (Pubitemid 41790697)
6. Brooks, C., Cho, S. G., Wang, C. Y., Yang, T. and Dong, Z. (2011). Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosis. Am. J. Physiol. 300, C447-C455.
7. Cassidy-Stone, A., Chipuk, J. E., Ingerman, E., Song, C., Yoo, C., Kuwana, T., Kurth, M. J., Shaw, J. T., Hinshaw, J. E., Green, D. R. et al. (2008). Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev. Cell 14, 193-204. (Pubitemid 351189177)
8. Czéh, B. and Lucassen, P. J. (2007). What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated? Eur. Arch. Psychiatry Clin. Neurosci. 257, 250-260. (Pubitemid 47301403)
9. Davis, R. E. and Williams, M. (2012). Mitochondrial function and dysfunction: an update. J. Pharmacol. Exp. Ther. 342, 598-607.
10. Egede, L. E. (2006). Disease-focused or integrated treatment: diabetes and depression. Med. Clin. North Am. 90, 627-646.
11. Eisch, A. J. and Petrik, D. (2012). Depression and hippocampal neurogenesis: a road to remission? Science 338, 72-75.
12. Grzeda, E., Wiśniewska, R. J. and Wiśniewski, K. (2007). Effect of an NMDA receptor agonist on T-maze and passive avoidance test in 12-week streptozotocin-induced diabetic rats. Pharmacol. Rep. 59, 656-663. (Pubitemid 351586556)
13. Hernández-Fonseca, J. P., Rincón, J., Pedreañez, A., Viera, N., Arcaya, J. L., Carrizo, E. and Mosquera, J. (2009). Structural and ultrastructural analysis of cerebral cortex, cerebellum, and hypothalamus from diabetic rats. Exp. Diabetes Res. 2009, 329632.
14. Hirano, S., Miyata, S. and Kamei, J. (2007). Antidepressant-like effect of leptin in streptozotocin-induced diabetic mice. Pharmacol. Biochem. Behav. 86, 27-31. (Pubitemid 46274966)
15. Ho, N., Balu, D. T., Hilario, M. R., Blendy, J. A. and Lucki, I. (2012). Depressive phenotypes evoked by experimental diabetes are reversed by insulin. Physiol. Behav. 105, 702-708.
16. Iosifescu, D. V. (2007). Treating depression in the medically ill. Psychiatr. Clin. North Am. 30, 77-90.
17. Itoh, K., Nakamura, K., Iijima, M. and Sesaki, H. (2013). Mitochondrial dynamics in neurodegeneration. Trends Cell Biol. 23, 64-71.
18. Jendrach, M., Mai, S., Pohl, S., Vöth, M. and Bereiter-Hahn, J. (2008). Short- and long-term alterations of mitochondrial morphology, dynamics and mtDNA after transient oxidative stress. Mitochondrion 8, 293-304.
19. Klein, A. B., Williamson, R., Santini, M. A., Clemmensen, C., Ettrup, A., Rios, M., Knudsen, G. M. and Aznar, S. (2011). Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int. J. Neuropsychopharmacol. 14, 347-353.
20. Krishnan, V. and Nestler, E. J. (2008). The molecular neurobiology of depression. Nature 455, 894-902.
21. Krishnan, V. and Nestler, E. J. (2011). Animal models of depression: molecular perspectives. Curr. Top. Behav. Neurosci. 7, 121-147.
22. Kumar, A., Haroon, E., Darwin, C., Pham, D., Ajilore, O., Rodriguez, G. and Mintz, J. (2008). Gray matter prefrontal changes in type 2 diabetes detected using MRI. J. Magn. Reson. Imaging 27, 14-19.
23. Laske, C., Stransky, E., Leyhe, T., Eschweiler, G. W., Wittorf, A., Richartz, E., Bartels, M., Buchkremer, G. and Schott, K. (2006). Stage-dependent BDNF serum concentrations in Alzheimer's disease. J. Neural Transm. 113, 1217-1224. (Pubitemid 44291016)
24. Lenzen, S. (2008). The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51, 216-226.
25. Liot, G., Bossy, B., Lubitz, S., Kushnareva, Y., Sejbuk, N. and Bossy-Wetzel, E. (2009). Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. Cell Death Differ. 16, 899-909.
26. Makino, A., Scott, B. T. and Dillmann, W. H. (2010). Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes. Diabetologia 53, 1783-1794.
27. Manczak, M. and Reddy, P. H. (2012). Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage. Hum. Mol. Genet. 21, 2538-2547.
28. Manczak, M., Calkins, M. J. and Reddy, P. H. (2011). Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Hum. Mol. Genet. 20, 2495-2509.
29. Martinowich, K., Manji, H. and Lu, B. (2007). New insights into BDNF function in depression and anxiety. Nat. Neurosci. 10, 1089-1093. (Pubitemid 47339961)
30. Men, X., Wang, H., Li, M., Cai, H., Xu, S., Zhang, W., Xu, Y., Ye, L., Yang, W., Wollheim, C. B. et al. (2009). Dynamin-related protein 1 mediates high glucose induced pancreatic beta cell apoptosis. Int. J. Biochem. Cell Biol. 41, 879-890.
31. Miyata, S., Hirano, S. and Kamei, J. (2005). Abnormal benzodiazepine receptor function in the depressive-like behavior of diabetic mice. Pharmacol. Biochem. Behav. 82, 615-620. (Pubitemid 43184036)
32. Molendijk, M. L., Spinhoven, P., Polak, M., Bus, B. A., Penninx, B. W. and Elzinga, B. M. (2013). Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484). Mol. Psychiatry [EPub ahead of print] doi:10.1038/mp.2013.105.
33. Montessuit, S., Somasekharan, S. P., Terrones, O., Lucken-Ardjomande, S., Herzig, S., Schwarzenbacher, R., Manstein, D. J., Bossy-Wetzel, E., Basañez, G., Meda, P. et al. (2010). Membrane remodeling induced by the dynamin-related protein Drp1 stimulates Bax oligomerization. Cell 142, 889-901.
34. Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V. and Ustun, B. (2007). Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370, 851-858. (Pubitemid 47362344)
35. Ranieri, M., Brajkovic, S., Riboldi, G., Ronchi, D., Rizzo, F., Bresolin, N., Corti, S. and Comi, G. P. (2013). Mitochondrial fusion proteins and human diseases. Neurol. Res. Int. 2013, 293893.
36. Regen, F., Merkl, A., Heuser, I., Dettling, M. and Anghelescu, I. (2005). [Diabetes and depression]. Dtsch. Med. Wochenschr. 130, 1097-1102.
37. Sanacora, G. and Banasr, M. (2013). From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders. Biol. Psychiatry 73, 1172-1179.
38. Savitz, J. and Drevets, W. C. (2009). Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci. Biobehav. Rev. 33, 699-771.
39. Schubert, M., Gautam, D., Surjo, D., Ueki, K., Baudler, S., Schubert, D., Kondo, T., Alber, J., Galldiks, N., Küstermann, E. et al. (2004). Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 101, 3100-3105. (Pubitemid 38327741)
40. Sepehry, A. A., Lee, P. E., Hsiung, G. Y., Beattie, B. L. and Jacova, C. (2012). Effect of selective serotonin reuptake inhibitors in Alzheimer's disease with comorbid depression: a meta-analysis of depression and cognitive outcomes. Drugs Aging 29, 793-806.
41. Sharma, A. N., Elased, K. M., Garrett, T. L. and Lucot, J. B. (2010). Neurobehavioral deficits in db/db diabetic mice. Physiol. Behav. 101, 381-388.
42. Shirendeb, U. P., Calkins, M. J., Manczak, M., Anekonda, V., Dufour, B., McBride, J. L., Mao, P. and Reddy, P. H. (2012). Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease. Hum. Mol. Genet. 21, 406-420.
43. Shrivastava, S. R., Shrivastava, P. S. and Ramasamy, J. (2013). Role of self-care in management of diabetes mellitus. J. Diabetes Metab. Disord. 12, 14-18.
44. Song, W., Chen, J., Petrilli, A., Liot, G., Klinglmayr, E., Zhou, Y., Poquiz, P., Tjong, J., Pouladi, M. A., Hayden, M. R. et al. (2011). Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat. Med. 17, 377-382.
45. Starkstein, S. E. and Mizrahi, R. (2006). Depression in Alzheimer's disease. Expert Rev. Neurother. 6, 887-895. (Pubitemid 43961889)
46. Stranahan, A. M., Arumugam, T. V., Cutler, R. G., Lee, K., Egan, J. M. and Mattson, M. P. (2008). Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat. Neurosci. 11, 309-317. (Pubitemid 351311802)
47. Suri, D. and Vaidya, V. A. (2013). Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity. Neuroscience 239, 196-213.
48. Takahashi, S., Izawa, Y. and Suzuki, N. (2012). Astroglial pentose phosphate pathway rates in response to high-glucose environments. ASN Neuro. 4, 71-88.
49. Teixeira, A. L., Barbosa, I. G., Diniz, B. S. and Kummer, A. (2010). Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomark. Med. 4, 871-887.
50. van Harten, B., Oosterman, J., Muslimovic, D., van Loon, B. J., Scheltens, P. and Weinstein, H. C. (2007). Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing 36, 164-170. (Pubitemid 46455395)
51. Videbech, P. and Ravnkilde, B. (2004). Hippocampal volume and depression: a meta-analysis of MRI studies. Am. J. Psychiatry 161, 1957-1966. (Pubitemid 39441394)
52. Vincent, A. M., Edwards, J. L., McLean, L. L., Hong, Y., Cerri, F., Lopez, I., Quattrini, A. and Feldman, E. L. (2010). Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy. Acta Neuropathol. 120, 477-489.
53. Watari, K., Elderkin-Thompson, V., Ajilore, O., Haroon, E., Darwin, C., Pham, D. and Kumar, A. (2008). Neuroanatomical correlates of executive functioning in depressed adults with type 2 diabetes. J. Clin. Exp. Neuropsychol. 30, 389-397. (Pubitemid 351563076)
54. Xi, G., Shen, X., Radhakrishnan, Y., Maile, L. and Clemmons, D. (2010). Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cells. Endocrinology 151, 3611-3623.
55. Yu, T., Sheu, S. S., Robotham, J. L. and Yoon, Y. (2008). Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc. Res. 79, 341-351. (Pubitemid 351951612)
56. Zunszain, P. A., Anacker, C., Cattaneo, A., Carvalho, L. A. and Pariante, C. M. (2011). Glucocorticoids, cytokines and brain abnormalities in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 722-729.